Skip to main content
. 2016 Nov 1;7(7):707–717.

Figure 1.

Figure 1

Daily iron chelation therapy should be considered to decrease iron overload for patients who have received more than 20 to 30 red blood cell (RBC) transfusions, particularly for lower-risk patients with myelodysplastic syndromes (MDS) and potential transplant patients. Information from NCCN (2016); Fenaux et al. (2014); Malcovati et al. (2013).